What is the appropriate workup for abnormal uterine bleeding in a woman presenting with missed, irregular periods and heavy bleeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Workup of Abnormal Uterine Bleeding

Start with transvaginal ultrasound (TVUS) combined with transabdominal ultrasound as your first-line imaging, obtain a complete blood count, pregnancy test, and thyroid function tests, then proceed to endometrial sampling based on age and risk factors 1.

Initial Clinical Assessment

Focus your history on these specific elements:

  • Bleeding pattern: Distinguish between heavy menstrual bleeding (predictable, cyclical) versus intermenstrual bleeding (irregular, non-cyclical) 2
  • Clot size: Clots ≥1 inch diameter predict heavy menstrual bleeding 3
  • "Flooding": Changing pad/tampon more frequently than hourly 3
  • Age: Critical for determining cancer risk and need for endometrial sampling
  • Bleeding disorder history: Personal or family history of bleeding suggests coagulopathy and warrants hematology referral 3

Laboratory Workup

Order these tests systematically:

  • Pregnancy test (β-hCG): Rule out pregnancy complications first—ectopic pregnancy is life-threatening 4
  • Complete blood count: Assess for anemia; low ferritin predicts heavy menstrual bleeding 3
  • Thyroid function tests: Thyroid dysfunction causes both anovulatory and ovulatory bleeding 5
  • Coagulation studies: If flooding, prolonged menses, or bleeding history present—von Willebrand disease is the most common coagulopathy 3, 5
  • Prolactin level: If oligomenorrhea or galactorrhea present 5

Imaging Strategy

TVUS is your primary imaging modality 1, 2:

  • Combines transvaginal (high resolution) with transabdominal (large uterus overview) approaches 1
  • Detects structural causes: fibroids, adenomyosis (82.5% sensitivity, 84.6% specificity), polyps 1
  • Critical age-based thresholds:
    • Postmenopausal: Endometrial thickness ≥5 mm requires endometrial sampling (4 mm cutoff has nearly 100% negative predictive value for cancer) 1
    • Premenopausal: No validated thickness cutoff exists—abnormal echogenicity and texture matter more than thickness 1

Add sonohysterography if TVUS shows focal endometrial abnormality—saline infusion improves characterization of polyps and submucosal fibroids 1, 5.

Reserve MRI for when ultrasound is inconclusive or the uterus is incompletely visualized—MRI has 79% sensitivity and 89% specificity for endometrial cancer, and 100% sensitivity/specificity for leiomyosarcoma 1.

Endometrial Sampling Indications

Perform endometrial biopsy in these scenarios 5:

  • Age ≥35 years with recurrent anovulation
  • Age <35 years with endometrial cancer risk factors (obesity, chronic anovulation, PCOS)
  • Excessive bleeding unresponsive to medical therapy
  • Postmenopausal bleeding with endometrial thickness ≥5 mm 1

Common Pitfalls

Don't rely on endometrial thickness alone in premenopausal women—even thickness <5 mm can harbor polyps or pathology 1. The evidence clearly shows thickness is not an indicator of endometrial pathology in this population.

Don't skip pregnancy testing—complications of pregnancy (ectopic, trophoblastic disease) can be life-threatening and delay in diagnosis worsens prognosis 4.

Don't miss coagulopathies—if the patient reports flooding, prolonged menses, or has a bleeding history, refer to hematology early 3. Up to 90% of women with underlying bleeding disorders experience heavy menstrual bleeding.

Age-Specific Considerations

Reproductive age with irregular periods: Think anovulation first—check for PCOS, thyroid dysfunction, hyperprolactinemia 5. These patients need endometrial protection from unopposed estrogen.

Reproductive age with heavy regular bleeding: Consider structural causes (fibroids, adenomyosis) or coagulopathies 2, 3. TVUS will identify most structural pathology.

Perimenopausal/postmenopausal: Endometrial cancer risk increases—lower threshold for endometrial sampling 1, 5.

References

Guideline

acr appropriateness criteria® abnormal uterine bleeding.

Journal of the American College of Radiology, 2020

Research

Heavy menstrual bleeding: work-up and management.

Hematology. American Society of Hematology. Education Program, 2016

Research

Evaluation of patients with abnormal uterine bleeding.

American journal of obstetrics and gynecology, 1996

Related Questions

What is the recommended evaluation and management for a reproductive‑age woman with menorrhagia, severe dysmenorrhea, large clots, and post‑menstrual brown spotting?
In a 44-year-old woman presenting to the emergency department with abnormal uterine bleeding, what laboratory and diagnostic workup is indicated?
How should I evaluate a 38-year-old woman with abnormal uterine bleeding to rule out a bleeding disorder?
What imaging modalities are recommended for evaluating heavy menstrual bleeding?
In a non‑pregnant patient with abnormal uterine bleeding, what does the presence of blood clots indicate?
What is the significance of a positive antinuclear antibody (ANA) titer of 1:80 with a nuclear dense fine speckled pattern in this patient?
What is the equivalent bumetanide dose for 240 mg furosemide (frusemide)?
What are the indications for ordering a carcinoembryonic antigen (CEA) test?
Provide a SOAP note for a 10‑year‑old female presenting for an annual well‑child visit, first dose of human papillomavirus (HPV) vaccine, Vanderbilt attention‑deficit/hyperactivity disorder (ADHD) assessment due to hyperactivity and difficulty reading and focusing, with a left shoulder drop observed on scoliosis screening, and include appropriate Current Procedural Terminology (CPT) and International Classification of Diseases, Tenth Revision (ICD‑10) codes.
An 80-year-old woman with a one‑month history of clear rhinorrhea, sneezing, and dry cough that has progressed to a productive cough after a camping trip, who has tried fexofenadine (Allegra), intranasal fluticasone propionate (Flonase), and benzonatate (Tessalon) without improvement and denies fever, chills, myalgias, sore throat, or dyspnea—what is the most likely diagnosis and what initial work‑up is recommended?
What dexamethasone dose should be given to an adult experiencing a COPD exacerbation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.